Publications by authors named "Mithun Devraj"
Article Synopsis
- Cardiac sarcoidosis (CS) is a growing cause of heart issues, but there’s limited understanding of how to treat it with TNF alpha inhibitors; this study examined treatment outcomes.* -
- In a study of 38 CS patients treated with TNF alpha inhibitors, corticosteroid use significantly decreased, and most showed improvement in cardiac inflammation, as indicated by FDG-PET imaging.* -
- While cardiac function remained stable, infections were frequently reported among patients, highlighting the need for careful monitoring for both infections and heart-related symptoms during treatment.*
Obesity, Systemic Hypertension, and Pulmonary Hypertension: A Tale of Three Diseases.
Curr Probl Cardiol
March 2021
Cardiovascular disease (CVD), especially ischemic heart disease and stroke, is the major cause of death worldwide, accounting for more than one-third of all deaths annually. Hypertension is the most prevalent and modifiable risk factor of CVD-related deaths. The same is true for obesity, which is currently being recognized as a major global epidemic.
View Article and Find Full Text PDFPermanent pacemaker (PPM) implantation remains common after transcatheter aortic valve implantation (TAVI). Invasive electrophysiology studies (EPSs) may reduce PPM implantation rates by identifying patients who do not require long-term pacing. At our institution, a new strategy in which patients with equivocal indications for pacing underwent EPSs to determine the need for PPM implantation was adopted.
View Article and Find Full Text PDF•We present two cases of advanced uterine cancer that were treated with the combination of metronomic cyclophosphamide and bevacizumab.•Targeting angiogenesis can provide disease control in patients with advanced uterine cancer.•Randomized controlled trials comparing metronomic and conventional regimens in advanced uterine cancer are required.
View Article and Find Full Text PDFExperience with biodegradable polymer coated sirolimus-eluting coronary stent system in "real-life" percutaneous coronary intervention: 24-month data from the manipal-s registry.
J Clin Diagn Res
September 2013
Introduction: Despite the undeniable clinical efficacy of drug-eluting stents with durable polymers, concerns regarding their long-term safety have been raised, especially in more complex subsets. The Manipal-S Registry was designed to evaluate the safety and effectiveness of the biodegradable polymer coated Supralimus(®) Sirolimus-Eluting Coronary Stent for the treatment of coronary artery disease, across a wide range of patients who are treated in real-life clinical practice.
Methods: All the consecutive 116 patients who underwent single-vessel or multiple vessel percutaneous coronary interventions with the use of Supralimus(®) sirolimus-eluting stents between September 2009 and December 2010, were included in this study.